ANCA-associated vasculitis is ANCA-associated vasculitis, which is mainly treated with medication and other therapies, and should be individualized according to the patient’s specific situation, and there is no so-called “optimal treatment method” at present. ANCA-associated vasculitis is a kind of vasculitis, in which ANCA is anti-neutrophil cytoplasmic antibody, the disease is characterized by necroinflammation, and the treatment is mainly based on medication, and the commonly used medications include glucocorticosteroids such as prednisone and methylprednisolone, and targeted medications such as mepolizumab and rituximab, etc. In addition to medication, severe cases of ANCA-associated vasculitis can be treated with other treatments. In addition to medication, severe ANCA-associated vasculitis can also be treated with immunoglobulin injections or plasma exchange, etc. Patients with ANCA-associated vasculitis should also ensure sufficient rest time and supplement nutrition. Drugs should be used under the guidance of a physician, and it is recommended that patients with ANCA-associated vasculitis go to the rheumatology and immunology department of a regular hospital for consultation and treatment as prescribed by the doctor.